BrightFlixx Launches $35M Cash Tender Offer for CVAT at ~$0.105/Share
CVAT sits 51% above its 52-week low of $0.022 on light trading volume (0.1× avg).
Summary
BrightFlixx commenced its $35 million all-cash tender offer for Cavitation Technologies at an initial estimated $0.105 per share, subject to a 90% tender threshold, CFIUS clearance and the concurrent Alchemy offer closing.
Key Events · M&A and Partnerships · CVAT
-
Tender Offer Commenced at ~$0.105/Share
BrightFlixx is offering $35,000,000 less CVAT's $738,000 liabilities, divided by 332,820,459 shares outstanding as of October 16, 2026 — an initial estimate of about $0.105 per share in cash.
-
Final Price Set December 24 Record Date
The binding per-share price is calculated at the close of the December 24, 2026 record date; the offer initially expires January 26, 2027 and must be extended at least 30 business days after the final price is announced.
-
Dilution Can Lower the Payout
11,269,400 warrant shares and 1,250,000 convertible-note shares could be exercised, and CVAT may issue up to 5,000,000 shares in a private placement before the record date — each increases the share count and reduces the final per-share price.
-
90% Threshold and Cross-Conditions
The offer requires 90% of CVAT shares tendered, CFIUS clearance, no material adverse effect, and successful completion of the concurrent $7,000,000 Alchemy Beverages tender offer; failure of either offer terminates both.
Analysis · CVAT · Industrial Applications And Services
The tender offer CVAT shareholders have awaited since the October 9 agreements is now live. BrightFlixx is offering $35 million in cash for all CVAT shares, less the company's liabilities, divided by shares outstanding — an initial estimate of about $0.105 per share versus the $0.03194 last trade on October 16, though the final number is not fixed until the December 24 record date. That price is highly sensitive to dilution: 11.3 million warrants and convertible notes plus up to 5 million new private-placement shares can be issued before the record date, each of which lowers the per-share payout. The deal needs 90% of shares tendered, CFIUS clearance, and the simultaneous closing of the $7 million Alchemy offer — if any leg fails, both offers terminate. A successful close means delisting from OTCQB and deregistration, so shareholders who do not tender could be left with illiquid stock.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 43.7% of the 286 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CVAT was trading at $0.03 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $10.6M. The 52-week trading range was $0.02 to $0.11. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.